Here we find that lung fibroblasts take up MDA-MB-231 breast cancer cell-derived EVs mainly through macropinocytosis and clathrin-independent, caveolae-mediated endocytosis, and that MEK inhibition by Trametinib mainly suppresses macropinocytosis. The gene discussed is MAP2K7; the disease is breast cancer.